anti-CD20 CAR-T in vivo assay
Posted 2023-12-27 07:09:42
0
2K

We have successfully developed various animal models for the in vivo assay of anti-CD 20 CAR-T cell therapy. Immunodeficiency mice are injected intravenously, subcutaneously, or intraperitoneally with CD20+ cells, such as lymphoma cell lines, CD20 transfected cell lines, human primary lymphoma cells, as well as customized cell lines to build up a murine B-cell malignancy model. Rat and non-human primate (NHP) models can be provided as well.
Search
Categories
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Games
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Other
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness
- IT, Cloud, Software and Technology
Read More
A Comprehensive Guide to Dentures and Tooth Extraction Services at Paradise Dental Smiles
When it comes to maintaining a beautiful, functional smile, professional dental care plays a...
Online Biology Teachers: Navigating the Future of Science Education
The digital age has revolutionized education, making it more accessible and flexible than ever...
Gynecological Devices Market Trends, Revenue, Major Players, Share Analysis & Forecast Till 2031
The global gynecological devices market reached USD 9.2 billion in 2022 and is expected to grow...
Key Demographics: Who's Buying Stuffed Animals?
The target market for stuffed animals spans multiple demographics, let's explore them....
The Digital Wound Measurement Devices Market is Estimated To Witness High Growth Owing To Increased Adoption of Advanced Wound Care Products
Digital wound measurement devices help in measuring chronic and acute wounds in an objective and...